medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 3

<< Back Next >>

Med Int Mex 2019; 35 (3)

Rheumatoid arthritis, autoantibodies, and PAD enzymes

Mercado U
Full text How to cite this article

Language: Spanish
References: 0
Page: 425-428
PDF size: 165.03 Kb.


Key words:

Rheumatoid arthritis, Autoantibodies to autoantigens, Peptidylarginine deiminase.

ABSTRACT

Rheumatoid arthritis is a systemic, inflammatory disease characterized by chronic synovitis and presence of autoantibodies. Risk factors include HLA-DRb1 genes, periodontal disease and smoking. At least 5 different autoantibodies to autoantigens are implicated in the pathogenesis of this disorder: 1) rheumatoid factor; 2) autoantibodies directed against citrullinated peptides/proteins (ACPA); 3) anti-carbamilated protein antibody (anti-carP); 4) anti-peptidylarginine deiminase antibody (anti-PAD2/4), and 5) anti-citrullinated fibrinogen antibody. Patients with rheumatoid arthritis have been divided into two disease subsets: ACPA-positive rheumatoid arthritis and ACPA-negative rheumatoid arthritis. ACPA-positive rheumatoid arthritis is associated with HLA-DRb1 shared epitope alleles and is recognized by antigen-specific T cells and B cells.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2019;35